Professor of Pathology, Beth Israel Deaconess Medical Center
Pathology
Dr. Stuart J. Schnitt, MD
|
|
Give Review
Stuart Schnitt practices Pathology. He researched medicine at Albany Medical College. He has 6 awards "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors", "Top MD" and "Super Doctor". Stuart Schnitt is a published physician. He has 94 papers published. The most current publication "Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Mult..." He is registered with Medicare and accepts Medicare payments.
Publications
- Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Mult...
- Current management of lesions associated with an increased risk of breast cancer.
- Diagnostic concordance among pathologists interpreting breast biopsy specimens.
- Does Isolated Flat Epithelial Atypia on Vacuum-assisted Breast Core Biopsy Require Surgical Excision?
- Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.
- Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.
- Digitized Whole Slides for Breast Pathology Interpretation: Current Practices and Perceptions.
- Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stag...
- Understanding Diagnostic Variability in Breast Pathology: Lessons Learned from an Expert Consensus Review Panel.
- Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
- Treatment of Ductal Carcinoma In Situ After Excision: Would a Prophylactic Paradigm Be More Appropriate?
- Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk.
- Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
- Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics.
- Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
- Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ.
- Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies.
- Significance analysis of prognostic signatures.
- Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.
- Evolutionary Pathways in BRCA1-Associated Breast Tumors.
- High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
- Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.
- Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
- Lifetime physical activity and the incidence of proliferative benign breast disease.
- COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin.
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
- Androgen receptor expression and breast cancer survival in postmenopausal women.
- The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemi...
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
- Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.
- Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.
- Thyroid transcription factor-1 expression in breast carcinomas.
- DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer.
- Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
- Will molecular classification replace traditional breast pathology?
- Molecular biology of breast tumor progression: a view from the other side.
- Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.
- Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.
- Clinging carcinoma: an American perspective.
- Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
- Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics.
- Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.
- Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
- Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue.
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
- Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
- Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.
- Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.
- Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
- Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
- Evolution of breast-conserving therapy for localized breast cancer.
- Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training.
- A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.
- Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.
- p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.
- Molecular definition of breast tumor heterogeneity.
- Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
- Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
- The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
- Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
- A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.
- Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
- Estrogen receptor testing of breast cancer in current clinical practice: what's the question?
- Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
- Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast.
- Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
- Early life factors and incidence of proliferative benign breast disease.
- MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883.
- Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonanc...
- Ultrahigh-resolution and 3-dimensional optical coherence tomography ex vivo imaging of the large and small intestines.
- HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.
- Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
- Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases.
- Magnetic resonance imaging of the breast prior to biopsy.
- Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
- A prospective study of diet and benign breast disease.
- Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
- HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.
- Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial.
- Adolescent diet and incidence of proliferative benign breast disease.
- Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
- Benign breast disease and breast cancer risk: morphology and beyond.
- Columnar cell lesions of the breast.
- Images in pathology. Conversation between needle biopsies.
- Pharmacopathology: a new spin on an old idea.
- Alcohol consumption and incidence of benign breast disease.
- Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?
- Family history of breast cancer, age and benign breast disease.
- (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study.
- Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation.
- MIB-1 Proliferation Index in Ductal Carcinoma In Situ of the Breast: Relationship to the Expression of the Apoptosis-Regulating Proteins bcl-2 and p53.
- Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients.
- Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.
Schools
Albany Medical College
Beth Israel Deaconess Hp M C
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Top MD
- Super Doctor
Education
-
Beth Israel Deaconess Medical Center -
Albany Medical College
Hospital
-
Beth Israel Deaconess Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821035452 |
| Last Name Of The Provider | SCHNITT |
| First Name Of The Provider | STUART |
| View All |
Similar Doctors
|
|
Dr. Lawrence R. Zukerberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen C. Blacklow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gayle L. Winters, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ji Yeon Kim, MD |
|
|
Dr. Sherrie R. White, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank S. David, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seymour Rosen, MD |
|
|
Dr. Frank Evangelista, MD |
|
|
Dr. Robert W. Pistey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shweta A. Shinagare, MD
This Doctor is OpenDoctor Recommended.
|